Dr Kylie Morphett

Dr Kylie Morphett completed her PhD in November 2016 and has since worked as a Research Fellow at the UQ School of Public Health. Prior to beginning her PhD, she worked in a number of non-profit health promotion project management roles. Her PhD research investigated how smokers understand the neuroscience of nicotine addiction and how this influences their sense of self-efficacy and choice of cessation methods. It also explored barriers to the use of best practice smoking cessation pharmacotherapies.

Dr Morphett's current research is focused on health communication related to tobacco and nicotine products. She has a strong interest in tobacco control policy and regulatory science, and is an investigator on a $5M NHMRC Synergy grant, where she leads the workstream on stakeholder support for tobacco endgame policies. She also has a strong interest in environmental health communication, and is an investigator on an NHMRC funded grant exploring the per- and polyfluoroalkyl substances (PFAS) exposome, leading the risk communication component of the project. She has expertise in mixed methods research, including systematic reviews, qualitative data design and analysis and the development and analysis of cross-sectional surveys.